Last week, on the cover of @NatureAging, we published the first computational framework for epigenetic age estimation at single-cell resolution. A fantastic collaboration with @CsabaKerepesi and @VadimGladyshev in the @gladyshev_lab @harvardmed! https://t.co/2QXfmVqXh4 1/🧵

Our Founder and CEO, @dullunlivin, takes the stage to talk about our advocacy efforts and the bipartisan Longevity Science Caucus!

Reaching this milestone has been truly significant for us. Please join us at the H-SPAN Summit at @Georgetown’s new Capitol Campus!

Hiring for a Head of Clinical! https://t.co/wZkrV2DIOM Interesting clinical trials to run and novel paths to carve for longevity therapeutics await.

Our first human clinical trial, now officially registered! (and starting soon 🤞) https://t.co/oQQV75EV1R

how a biologist sees the world

33 Things I've Learned at 33 https://t.co/4xmauoHhgj

New in Nature Reviews Genetics: my Review on how advanced genomic technologies are redefining cellular reprogramming: mapping trajectories, dissecting chromatin dynamics, + lineage tracing & synthetic circuits to push the boundaries of cell identity. https://t.co/8NBM5ohxkJ

inspired by recent events: tomorrow i will publish an article about why you should work in biology because at some point in your life—maybe not today, but someday—you’ll realize that it is the only field that actually mattered, so you might as well start now

At @OpenAI, we believe that AI can accelerate science and drug discovery. An exciting example is our work with @RetroBiosciences, where a custom model designed improved variants of the Nobel-prize winning Yamanaka proteins. Today we published a closer look at the breakthrough. ⬇️

the average PLR contributor

Ideas people often bring up when discussing automation in biotech: - AI scientists - cloud labs - a shareable format for protocols - vision driven validation systems No one is more excited about these things than I am, but how will we get there without building a decent

I'm thrilled to share our new paper in Nature Immunology! Spatial proteomics of Alzheimer’s disease-specific human microglial states: https://t.co/VvKI36NhfX — the culmination of my postdoc at @Stanford @StanfordMed in the @Bendall_Lab and lab of Thomas Montine! 🧠✨

We're just as excited about the new ARPA-H program, FRONT, as you are! It's truly transformative for patients currently suffering from permanent neurological damage with no immediate cure.

NEW: No technology currently exists to repair damaged brain tissue and fully restore lost function. FRONT aims to enable millions with what is considered permanent brain damage to regain lost functions, including motor control, vision, and speech.

Excited to share our new publication! We previously showed that age reversal can be achieved using transcription factor-based reprogramming. Now, we demonstrate that it can also be done with chemical cocktails to achieve lifespan extension! https://t.co/hxgIhAOW0U

Thrilled to have joined Nabil Laoudji (@nabilwrites) on his podcast, Discovery Engines. We talked about the founding story and mission behind PyLabRobot: building open, universal lab automation that empowers scientists everywhere. Check out the episode below!

What if we could integrate, play with, and control lab hardware as easily as we do software? That’s the vision behind @pylabrobot, an open-source, hardware-agnostic Python SDK building a universal interface for lab automation. I sat down with its creator, @rickwierenga, to

cool to see @davidasinclair share the news article i wrote with some @RetroBio_ scientists about recent work @altos_labs. super excited for the future of partial reprogramming therapies - stay tuned

The biggest obstacle to curing diseases w/ AI is data! Quality & quantity. Bio data pales in comparison to NLP or comp vision. Also, due to scientific fads, existing data likely captures only a sliver of possible info/signal in biology. Data is the key to BioXAI impact!

Why test #celltherapies one-by-one when you can use multiplexed #SynBio, #proteinengineering & #ML to design, measure & track them at scale? The Goodman Lab @PennMedicine opens July 2025. We’re hiring Specialists & Postdocs! Apply @ https://t.co/DE7aPLp9vr RTs appreciated!🙏